ABBVIE INC (4AB.DE) Fundamental Analysis & Valuation
FRA:4AB • US00287Y1091
Current stock price
178.6 EUR
-2.6 (-1.43%)
Last:
This 4AB.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. 4AB.DE Profitability Analysis
1.1 Basic Checks
- 4AB had positive earnings in the past year.
- In the past year 4AB had a positive cash flow from operations.
- In the past 5 years 4AB has always been profitable.
- Each year in the past 5 years 4AB had a positive operating cash flow.
1.2 Ratios
- The Return On Assets of 4AB (3.12%) is better than 74.07% of its industry peers.
- The Return On Invested Capital of 4AB (14.42%) is better than 93.83% of its industry peers.
- 4AB had an Average Return On Invested Capital over the past 3 years of 12.12%. This is in line with the industry average of 11.34%.
- The last Return On Invested Capital (14.42%) for 4AB is above the 3 year average (12.12%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.12% | ||
| ROE | N/A | ||
| ROIC | 14.42% |
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
1.3 Margins
- With a decent Profit Margin value of 6.84%, 4AB is doing good in the industry, outperforming 74.07% of the companies in the same industry.
- In the last couple of years the Profit Margin of 4AB has declined.
- Looking at the Operating Margin, with a value of 34.23%, 4AB belongs to the top of the industry, outperforming 91.36% of the companies in the same industry.
- In the last couple of years the Operating Margin of 4AB has grown nicely.
- With a decent Gross Margin value of 71.62%, 4AB is doing good in the industry, outperforming 60.49% of the companies in the same industry.
- 4AB's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 34.23% | ||
| PM (TTM) | 6.84% | ||
| GM | 71.62% |
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
2. 4AB.DE Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 4AB is creating some value.
- Compared to 1 year ago, 4AB has about the same amount of shares outstanding.
- The number of shares outstanding for 4AB remains at a similar level compared to 5 years ago.
- The debt/assets ratio for 4AB is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 2.28 indicates that 4AB is not a great score, but indicates only limited risk for bankruptcy at the moment.
- 4AB has a better Altman-Z score (2.28) than 62.96% of its industry peers.
- 4AB has a debt to FCF ratio of 3.79. This is a good value and a sign of high solvency as 4AB would need 3.79 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 3.79, 4AB belongs to the top of the industry, outperforming 82.72% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.79 | ||
| Altman-Z | 2.28 |
ROIC/WACC1.78
WACC8.09%
2.3 Liquidity
- A Current Ratio of 0.67 indicates that 4AB may have some problems paying its short term obligations.
- Looking at the Current ratio, with a value of 0.67, 4AB is doing worse than 79.01% of the companies in the same industry.
- A Quick Ratio of 0.56 indicates that 4AB may have some problems paying its short term obligations.
- 4AB has a Quick ratio of 0.56. This is amonst the worse of the industry: 4AB underperforms 80.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.56 |
3. 4AB.DE Growth Analysis
3.1 Past
- The earnings per share for 4AB have decreased by -1.19% in the last year.
- Measured over the past years, 4AB shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.99% on average per year.
- The Revenue has grown by 8.57% in the past year. This is quite good.
- Measured over the past years, 4AB shows a small growth in Revenue. The Revenue has been growing by 5.95% on average per year.
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
3.2 Future
- Based on estimates for the next years, 4AB will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.08% on average per year.
- Based on estimates for the next years, 4AB will show a small growth in Revenue. The Revenue will grow by 6.43% on average per year.
EPS Next Y48.4%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue Next Year10.06%
Revenue Next 2Y9.09%
Revenue Next 3Y8.46%
Revenue Next 5Y6.43%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. 4AB.DE Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 20.65, 4AB is valued on the expensive side.
- 4AB's Price/Earnings ratio is rather cheap when compared to the industry. 4AB is cheaper than 81.48% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 25.23. 4AB is around the same levels.
- With a Price/Forward Earnings ratio of 13.91, 4AB is valued correctly.
- Based on the Price/Forward Earnings ratio, 4AB is valued cheaper than 91.36% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of 4AB to the average of the S&P500 Index (23.28), we can say 4AB is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.65 | ||
| Fwd PE | 13.91 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 4AB indicates a rather cheap valuation: 4AB is cheaper than 80.25% of the companies listed in the same industry.
- Based on the Price/Free Cash Flow ratio, 4AB is valued cheaply inside the industry as 87.65% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.48 | ||
| EV/EBITDA | 14.6 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of 4AB may justify a higher PE ratio.
- 4AB's earnings are expected to grow with 22.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.43
PEG (5Y)N/A
EPS Next 2Y28.14%
EPS Next 3Y22.01%
5. 4AB.DE Dividend Analysis
5.1 Amount
- 4AB has a Yearly Dividend Yield of 3.36%.
- Compared to an average industry Dividend Yield of 0.60, 4AB pays a better dividend. On top of this 4AB pays more dividend than 97.53% of the companies listed in the same industry.
- 4AB's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.36% |
5.2 History
- On average, the dividend of 4AB grows each year by 6.76%, which is quite nice.
Dividend Growth(5Y)6.76%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
- 4AB pays out 278.48% of its income as dividend. This is not a sustainable payout ratio.
- The dividend of 4AB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP278.48%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
4AB.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:4AB (3/20/2026, 7:00:00 PM)
178.6
-2.6 (-1.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)04-23 2026-04-23/bmo
Inst Owners76.17%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap315.80B
Revenue(TTM)61.16B
Net Income(TTM)4.19B
Analysts77.44
Price Target216.59 (21.27%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.36% |
Yearly Dividend5.71
Dividend Growth(5Y)6.76%
DP278.48%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.46%
Min EPS beat(2)0.18%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.25%
Min EPS beat(4)0.18%
Max EPS beat(4)2.75%
EPS beat(8)8
Avg EPS beat(8)1.12%
EPS beat(12)10
Avg EPS beat(12)0.74%
EPS beat(16)12
Avg EPS beat(16)0.58%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)-0.78%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)5
Avg Revenue beat(16)-0.64%
PT rev (1m)1.22%
PT rev (3m)1.57%
EPS NQ rev (1m)0.56%
EPS NQ rev (3m)-2.63%
EPS NY rev (1m)2.19%
EPS NY rev (3m)2.16%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)-0.79%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)0.6%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.65 | ||
| Fwd PE | 13.91 | ||
| P/S | 5.97 | ||
| P/FCF | 20.48 | ||
| P/OCF | 19.18 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.6 |
EPS(TTM)8.65
EY4.84%
EPS(NY)12.84
Fwd EY7.19%
FCF(TTM)8.72
FCFY4.88%
OCF(TTM)9.31
OCFY5.22%
SpS29.93
BVpS-1.6
TBVpS-44.81
PEG (NY)0.43
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.12% | ||
| ROE | N/A | ||
| ROCE | 23.09% | ||
| ROIC | 14.42% | ||
| ROICexc | 15.28% | ||
| ROICexgc | N/A | ||
| OM | 34.23% | ||
| PM (TTM) | 6.84% | ||
| GM | 71.62% | ||
| FCFM | 29.13% |
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ROICexc(3y)13.19%
ROICexc(5y)12.96%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.1%
ROCE(5y)18.64%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y5.79%
ROICexc growth 5Y14.56%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
F-Score8
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.79 | ||
| Debt/EBITDA | 2.11 | ||
| Cap/Depr | 14.92% | ||
| Cap/Sales | 1.98% | ||
| Interest Coverage | 6.97 | ||
| Cash Conversion | 65.45% | ||
| Profit Quality | 425.61% | ||
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.56 | ||
| Altman-Z | 2.28 |
F-Score8
WACC8.09%
ROIC/WACC1.78
Cap/Depr(3y)11.82%
Cap/Depr(5y)10.58%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.55%
Profit Quality(3y)434.7%
Profit Quality(5y)340.33%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
EPS Next Y48.4%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
Revenue Next Year10.06%
Revenue Next 2Y9.09%
Revenue Next 3Y8.46%
Revenue Next 5Y6.43%
EBIT growth 1Y26.92%
EBIT growth 3Y1.33%
EBIT growth 5Y8.87%
EBIT Next Year42.07%
EBIT Next 3Y19.5%
EBIT Next 5Y10.21%
FCF growth 1Y-0.09%
FCF growth 3Y-9.76%
FCF growth 5Y1.19%
OCF growth 1Y1.19%
OCF growth 3Y-8.62%
OCF growth 5Y1.59%
ABBVIE INC / 4AB.DE Fundamental Analysis FAQ
What is the ChartMill fundamental rating of ABBVIE INC (4AB.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to 4AB.DE.
What is the valuation status for 4AB stock?
ChartMill assigns a valuation rating of 7 / 10 to ABBVIE INC (4AB.DE). This can be considered as Undervalued.
How profitable is ABBVIE INC (4AB.DE) stock?
ABBVIE INC (4AB.DE) has a profitability rating of 7 / 10.
Can you provide the financial health for 4AB stock?
The financial health rating of ABBVIE INC (4AB.DE) is 4 / 10.
How sustainable is the dividend of ABBVIE INC (4AB.DE) stock?
The dividend rating of ABBVIE INC (4AB.DE) is 6 / 10 and the dividend payout ratio is 278.48%.